Cardiovascular

Intensive Glycaemic Control: Meta Analysis Confirms Benefit In Type II Diabetes

June 23, 2009
Source: 19th European Meeting On Hypertension, Milan, June 12-16, 2009
Peter Nilsson

Peter Nilsson

Peter Nilsson explains to Peter Goodwin his clear recommendation that doctors should manage hyperglycaemia aggressively in patients with Type II diabetes following his discussions in Milan about the meta-analysis of five big studies recently published in The Lancet which confirms a reduction of cardiovascular events. He also discusses Early Vascular Aging (EVA) and what to do about it, namely to use: ADAM: Aggressive Decrease of Atherosclerosis Modifiers.

Download this interview

Add podcast to iTunes

Similar Interviews

  • Meta-Analysis Proves Statins Help Patients With Diabetes

    • Colin Baigent REFERENCE: Lancet 371:117 January 11, 2008 COLIN BAIGENT, Oxford University

  • Rosiglitazone for Patients with Diabetes: Cardiovascular Outcomes Trial Findings

    • Stuart Pocock REFERENCE: ABSTRACT N Engl J Med 2007; 357: 28-381 STUART POCOCK, London School of

  • Audio Journal of Cardiovascular Medicine 10.3, May 2004

    • Reporting from: European Society of Cardiology Congress, Munich, August 28-1 September, 2004 Scientific Editors: Michael Petch, Papworth Hospital, Cambridge Man Fai Shiu, Walsgrave Hospital,

    Post a comment